PIZZUTI DANA (Chief Development Officer) sold 7.0% of their position (5K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $225.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0001628280-25-055054
Officer· Chief Development Officer
Since Sep 2022
-5K
Net shares
Net seller
$225.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$16.89
Trade value
$84.45K
% of position
7.5%
12/1/2025
66.84K→71.84K
Common Stock
Direct
Shares
−5K
Price / share
$45.02
Trade value
$225.10K
% of position
7.0%
12/1/2025
71.84K→66.84K
Total
Net shares
+0.00
Net value
-$140.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | M · Option Exercise | +5K | $16.89 | $84.45K | 7.5% | 66.84K | 71.84K |
| Common Stock Direct | 12/1/2025 | S · Sale | −5K | $45.02 | $225.10K | 7.0% | 71.84K | 66.84K |
| Total | +0.00 | -$140.65K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
16.89
Held after
69.04K
Exercisable
—
12/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 12/1/2025 | M · Option Exercise | −5K | 16.89 | — | 69.04K |